SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-010242
Filing Date
2021-01-15
Accepted
2021-01-15 17:23:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d106529d424b5.htm 424B5 345732
2 GRAPHIC g106529cov.jpg GRAPHIC 3047
3 GRAPHIC g106529g02k59.jpg GRAPHIC 62153
4 GRAPHIC g106529g02p33.jpg GRAPHIC 42426
  Complete submission text file 0001193125-21-010242.txt   495279
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251161 | Film No.: 21533104
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences